202 related articles for article (PubMed ID: 9466172)
1. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.
Tiller JW; Bouwer C; Behnke K
Int Clin Psychopharmacol; 1997 Oct; 12 Suppl 6():S27-30. PubMed ID: 9466172
[TBL] [Abstract][Full Text] [Related]
2. Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
Tiller JW; Bouwer C; Behnke K
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S7-10. PubMed ID: 10361960
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
Krüger MB; Dahl AA
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S19-24. PubMed ID: 10361962
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders.
Williams R; Edwards RA; Newburn GM; Mullen R; Menkes DB; Segkar C
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):155-8. PubMed ID: 8468437
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients.
Hawley CJ; Quick SJ; Ratnam S; Pattinson HA; McPhee S
Int Clin Psychopharmacol; 1996 Sep; 11(3):187-91. PubMed ID: 8923097
[TBL] [Abstract][Full Text] [Related]
6. Reversible monoamine-A inhibitors in panic disorder.
Bakish D
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():432A-433A. PubMed ID: 1498904
[No Abstract] [Full Text] [Related]
7. Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.
Lonnqvist J; Sintonen H; Syvälahti E; Appelberg B; Koskinen T; Mannikko T; Mehtonen OP; Naarala M; Sihvo S; Auvinen J
Acta Psychiatr Scand; 1994 Jun; 89(6):363-9. PubMed ID: 8085464
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
9. Moclobemide: therapeutic use and clinical studies.
Bonnet U
CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
[TBL] [Abstract][Full Text] [Related]
10. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
Priest RG; Gimbrett R; Roberts M; Steinert J
Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide versus fluoxetine in the treatment of inpatients with major depression.
Gattaz WF; Vogel P; Kick H; Kohnen R
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):35S-40S. PubMed ID: 7593728
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
Versiani M; Nardi AE; Figueira IL; Stabl M
Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
[TBL] [Abstract][Full Text] [Related]
14. Combined SSRI-moclobemide treatment of psychiatric illness.
Joffe RT; Bakish D
J Clin Psychiatry; 1994 Jan; 55(1):24-5. PubMed ID: 8294388
[TBL] [Abstract][Full Text] [Related]
15. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
Botte L; Gilles C; Evrard JL; Mesters P; Wolfrum C; Berger M; Hellstern K; Ward J
Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066
[TBL] [Abstract][Full Text] [Related]
16. Serotonin syndrome with moclobemide-fluoxetine combination.
Benazzi F
Pharmacopsychiatry; 1996 Jul; 29(4):162. PubMed ID: 8858717
[No Abstract] [Full Text] [Related]
17. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
Baumhackl U; Bizière K; Fischbach R; Geretsegger C; Hebenstreit G; Radmayr E; Stabl M
Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
Lecrubier Y; Guelfi JD
Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
[TBL] [Abstract][Full Text] [Related]
20. Moclobemide versus fluoxetine for major depressive episodes.
Geerts S; Bruynooghe F; De Cuyper H; Demeulemeester F; Haazen L
Clin Neuropharmacol; 1994; 17 Suppl 1():S50-7. PubMed ID: 7954484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
